SEARCH RESULTS

Results for "Research"

18. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa

Shalom Lloyd,  after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020. 

9. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa

Shalom Lloyd,  after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020. 

306. Bonus: Victoria Barbary of the International Forum of Sovereign Wealth Funds – at the intersection of politics, macroeconomics and finance

Victoria Barbary  is Director of Strategy & Communications for the International Forum of Sovereign Wealth Funds (IFSWF) in which her focus is to help sovereign wealth funds become better investors for the benefit of their citizens.  She formerly worked in research roles relating to Sovereign Wealth Funds and prior to that was a PhD student in the field of Victorian History.

285. Lindsey Stewart of Morningstar Sustainanalytics: on Moon Shots – large and small

Lindsey Stewart is Director of Stewardship Research and Policy at Morningstar Sustainanalytics, where he is a sustainability and governance specialist. Based in London he writes regularly about how institutional investors engage with companies and policymakers on environmental, social and governance themes and is a regular speaker on these topics. He previously was head of Stakeholder Engagement at the Financial Reporting Council and spent 8 years at KPMG in various engagement roles.

283. Michael Tiedemann of AlTi: Building a Firm – The Role of Talent and Motivation

Mike Tiedemann was a Founding Partner, CEO and Chairman of the Internal Investment Committee at Tiedemann Advisors, as well as CEO at Tiedemann Investment Group (TIG), before leading the merger that created AlTi. Early in his career, Mike lived and worked in Brazil as part of the equity research group at Banco Garantia and later ran the equity sales and trading operations for Latin America.

Bonus Episode – Margaret Casely-Hayford CBE – A Champion of Change and Progress pursues her next Challenge

Margaret Casely-Hayford, CBE, until recently was Chancellor of Coventry University, a role she held for close to 7 years.  She has had an extensive career having been a partner at Dentons in legal practice for close to 20 years, and has held roles as NED of the NHS, as a Special Trustee at Great Ormond Street Hospital Childrens’ Charity, Chair at Shakespeares’ Globe, and as a Board Member of Co-op, to name just a few. We featured her on our podcast in February 2021, where we discussed her role as a champion for diversity in the law and are delighted to now welcome her back to discuss her candidacy for the Chancellorship at Oxford University, an institution of which she is herself an alumna

277. Shan Chen: AI Pathbreaker: Tales from the Crucible of Public Fund Innovation

Shan Chen was until recently a portfolio manager focused on mostly private investments at the Arizona Public Safety Personnel Retirement System, where he spent over 17 years. He previously worked primarily within information technology and did research work in biochemistry. He has recently retired from the PSPRS and is focusing full time on developing AI solutions for investment management.